Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19

Andreas Weiss; Ewan Donnachie; Andreas Beyerlein; Anette-G Ziegler; Ezio Bonifacio

doi:10.1001/jama.2023.8674

Type 1 Diabetes Incidence and Risk in Children With a Diagnosis of COVID-19

JAMA. 2023 Jun 20;329(23):2089-2091. doi: 10.1001/jama.2023.8674.

Authors

Andreas Weiss¹, Ewan Donnachie², Andreas Beyerlein³, Anette-G Ziegler¹, Ezio Bonifacio⁴

Affiliations

¹ Institute of Diabetes Research, Helmholtz Munich, Munich, Germany.
² Kassenärztliche Vereinigung Bayern (Bavarian Association of Statutory Health Insurance Physicians), Munich, Germany.
³ Bavarian Health and Food Safety Authority, Oberschleissheim, Germany.
⁴ Center for Regenerative Therapies Dresden, Technische Universität Dresden, Dresden, Germany.

No abstract available

Plain language summary

This study used a population-based individual patient data set that included diagnoses of COVID-19 to determine whether there was a temporal association between COVID-19 and type 1 diabetes in children.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

COVID-19 Testing
COVID-19* / complications
COVID-19* / diagnosis
COVID-19* / epidemiology
Child
Diabetes Mellitus, Type 1* / complications
Diabetes Mellitus, Type 1* / diagnosis
Diabetes Mellitus, Type 1* / epidemiology
Humans
Incidence
Risk Factors